Hospital or health organisation · founded 1881
Hackensack University Medical Center
Hackensack, United States · hackensackumc.org
- Citations, last 5 years
- 18.4k
- Works, last 5 years
- 2 510
- h-index
- 322
- Scientists listed
- 0
- Grants since 2016
- 224
Grants received
2025–2030 · research · R01
Dissecting the molecular targets to overcome beta-lactam resistance in M. abscessus complex
Barry Neal Kreiswirth · Hackensack University Medical Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U01
Dissecting the host-plasmid interplay to unravel the spread of ESBL-producing K. pneumoniae
Barry Neal Kreiswirth · Hackensack University Medical Center · funded by National Institutes of Health
2025–2029 · research · R01
TLE transcription cofactors in anti-viral and anti-tumor immunity
Hai-Hui Xue · Hackensack University Medical Center · funded by National Institutes of Health
2025–2027 · research · R21
Effects of antifungal drug treatment and immune dysfunction on the evolutionary dynamics of gut-colonizing Candida glabrata
Erika Shor · Hackensack University Medical Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U19
Center for accelerated development of drug candidates targeting high threat bacterial infections
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2025–2029 · research · R01
Shorter and more effective oral regimens for M. abscessus pulmonary disease
Thomas Dick · Hackensack University Medical Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U19
Center for accelerated development of drug candidates targeting high threat bacterial infections
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U19
Medicinal Chemistry Core
James M Balkovec · Hackensack University Medical Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U19
Therapeutics for drug-resistant bacteria: arylmyxopyronins
Richard H. Ebright · Hackensack University Medical Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U19
Lead Optimization and Preclinical Development of a small molecule inhibitor of M. avium KasA
David Alland · Hackensack University Medical Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U19
Advanced development of a potent dual-targeting TriBE class lead candidate to treat highly drug resistant Neisseria gonorrhoeae
David S Perlin · Hackensack University Medical Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U19
Novel rifamycins to improve cure rates and shorten treatment of M. abscessus lung disease
Thomas Dick · Hackensack University Medical Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U19
Pharmacology Core
Vidmantas Petraitis · Hackensack University Medical Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U19
Animal Model and Microbiology Core
Andrew Nelson · Hackensack University Medical Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U19
Pre-clinical Safety and Toxicology Studies of a PO-administered b-lactam-tarocin combination agent to treat methicillin susceptible and resistant staphylococci
Terry Roemer · Hackensack University Medical Center · funded by National Institutes of Health
2024–2025 · research · R01
Dissecting cell composition and drug sensitivity in human adenoid cystic carcinomas (ACCs)
Piero D Dalerba · Hackensack University Medical Center · funded by National Institutes of Health
2024–2025 · career development · K22
Cancer Misinformation and Use of Complementary and Alternative Therapy (CAM) among Patients with Cancer.
Ilona Fridman · Hackensack University Medical Center · funded by National Institutes of Health
2024–2027 · grant · BCRP
Therapeutic Implications of TNBC-Specific ETV6 Rearrangements: Chemoresistance and Immune Evasion
Binfeng Lu · Hackensack University Medical Center · funded by Congressionally Directed Medical Research Programs
2024–2029 · research · R01
Celiac and inflammatory bowel diseases: functional post-GWAS approach
Kathryn Elizabeth Hamilton · Hackensack University Medical Center · funded by National Institutes of Health
2024–2029 · research · R01
ID3 regulation of tissue-infiltrating T cells mediating graft-versus-host disease and leukemia rejection
Hai-Hui Xue · Hackensack University Medical Center · funded by National Institutes of Health
2024–2029 · research · R01
Neutrophil extracellular traps and associated pathogenesis in TBI: a novel peptide therapeutic strategy.
Mohammed Abdul Muneer · Hackensack University Medical Center · funded by National Institutes of Health
2024–2027 · career development · K22
Cancer Misinformation and Use of Complementary and Alternative Therapy (CAM) among Patients with Cancer.
Ilona Fridman · Hackensack University Medical Center · funded by National Institutes of Health
2024–2026 · research · R21
C25-modified rifabutin analogs as a novel medicinal chemistry strategy to overcome drug-resistant tuberculosis
Uday Ganapathy · Hackensack University Medical Center · funded by National Institutes of Health
2024–2029 · research · R01
Tissue specific immunity to fungal infections
Neeraj Chauhan · Hackensack University Medical Center · funded by National Institutes of Health
2024–2029 · research · R01
ID3 regulation of tissue-infiltrating T cells mediating graft-versus-host disease and leukemia rejection
Hai-Hui Xue · Hackensack University Medical Center · funded by National Institutes of Health
2024–2029 · research · R01
Celiac and inflammatory bowel diseases: functional post-GWAS approach
Kathryn Elizabeth Hamilton · Hackensack University Medical Center · funded by National Institutes of Health
2024–2025 · research · R01
Neutrophil extracellular traps and associated pathogenesis in TBI: a novel peptide therapeutic strategy.
Mohammed Abdul Muneer · Hackensack University Medical Center · funded by National Institutes of Health
2023–2025 · cooperative agreement · UG3
Enriching ECHO Cohorts with High-risk Pregnancies and Children with Disabilities (Enriching ECHO)
Judy Lynn Aschner · Hackensack University Medical Center · funded by National Institutes of Health
2023–2028 · research · R01
Nuclear envelope and predisposition to hepatic neoplasia
Ji-Yeon Shin · Hackensack University Medical Center · funded by National Institutes of Health
2023–2028 · research · R01
Optimization of rifamycins to overcome intrinsic resistance of nontuberculous mycobacteria to improve treatment of NTM lung disease
Courtney C Aldrich · Hackensack University Medical Center · funded by National Institutes of Health
2023–2028 · research · R01
Nuclear envelope and predisposition to hepatic neoplasia
Ji-Yeon Shin · Hackensack University Medical Center · funded by National Institutes of Health
2023–2025 · cooperative agreement · UG3
Enriching ECHO Cohorts with High-risk Pregnancies and Children with Disabilities (Enriching ECHO)
Judy Lynn Aschner · Hackensack University Medical Center · funded by National Institutes of Health
2023–2025 · research · R21
Peptide therapy for alcohol-induced CNS injury
Mohammed Abdul Muneer · Hackensack University Medical Center · funded by National Institutes of Health
2023–2028 · research · R01
Optimization of rifamycins to overcome intrinsic resistance of nontuberculous mycobacteria to improve treatment of NTM lung disease
Courtney C Aldrich · Hackensack University Medical Center · funded by National Institutes of Health
2023–2028 · research · R01
Identifying and characterizing functional noncoding mutations in multiple myeloma
Benjamin Tycko · Hackensack University Medical Center · funded by National Institutes of Health
2023–2026 · grant · PRP
Mechanisms of Impaired Swallowing, Speech, and Voice in Parkinson's Disease
Lancai Mu · Hackensack University Medical Center · funded by Congressionally Directed Medical Research Programs
2023–2028 · research · R01
Identifying and characterizing functional noncoding mutations in multiple myeloma
Benjamin Tycko · Hackensack University Medical Center · funded by National Institutes of Health
2023–2025 · research · R21
Peptide therapy for alcohol-induced CNS injury
Mohammed Abdul Muneer · Hackensack University Medical Center · funded by National Institutes of Health
2023 · research · CARRA- Arthritis Foundation Large Grant
Initial Validation of the Pain and Symptom Assessment Tool in Juvenile Fibromyalgia Syndrome
Jennifer Weiss · Hackensack University Medical Center · funded by Arthritis Foundation
2023–2028 · research · R01
Nuclear envelope and predisposition to hepatic neoplasia
Ji-Yeon Shin · Hackensack University Medical Center · funded by National Institutes of Health